Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization

Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization Publisher Pubmed

Summary: New inhibitors targeting MAGL show promise for treating central and peripheral diseases by boosting brain signaling, research finds. #Neuroscience #DrugDevelopment

Butini S¹ ; Grether U² ; Jung KM³ ; Ligresti A⁴ ; Allara M⁴ ; Postmus AGJ⁵ ; Maramai S¹ ; Brogi S⁶ ; Papa A¹ ; Carullo G¹ ; Sykes D^{7, 8} ; Veprintsev D⁷ ; Federico S¹ ; Grillo A¹ Show All Authors

Butini S¹
Grether U²
Jung KM³
Ligresti A⁴
Allara M⁴
Postmus AGJ⁵
Maramai S¹
Brogi S⁶
Papa A¹
Carullo G¹
Sykes D^{7, 8}
Veprintsev D⁷
Federico S¹
Grillo A¹
Di Guglielmo B¹
Ramunno A⁹
Stevens AF⁵
Heer D²
Lamponi S¹
Gemma S¹
Benz J²
Di Marzo V^{4, 10, 11, 12, 13}
Van Der Stelt M⁵
Piomelli D³
Campiani G^{1, 14}

Source: Journal of Medicinal Chemistry Published:2024

Abstract

New potent, selective monoacylglycerol lipase (MAGL) inhibitors based on the azetidin-2-one scaffold ((±)-5a-v, (±)-6a-j, and (±)-7a-d) were developed as irreversible ligands, as demonstrated by enzymatic and crystallographic studies for (±)-5d, (±)-5l, and (±)-5r. X-ray analyses combined with extensive computational studies allowed us to clarify the binding mode of the compounds. 5v was identified as selective for MAGL when compared with other serine hydrolases. Solubility, in vitro metabolic stability, cytotoxicity, and absence of mutagenicity were determined for selected analogues. The most promising compounds ((±)-5c, (±)-5d, and (±)-5v) were used for in vivo studies in mice, showing a decrease in MAGL activity and increased 2-arachidonoyl-sn-glycerol levels in forebrain tissue. In particular, 5v is characterized by a high eudysmic ratio and (3R,4S)-5v is one of the most potent irreversible inhibitors of h/mMAGL identified thus far. These results suggest that the new MAGL inhibitors have therapeutic potential for different central and peripheral pathologies. © 2024 American Chemical Society.

2. Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments, Research in Pharmaceutical Sciences (2020)

3. Design, Synthesis, and Evaluation of Triazolo[1,5-A]Pyridines As Novel and Potent Α‑Glucosidase Inhibitors, Scientific Reports (2025)

Experts (# of related papers)

View all Related Experts

Farshid Hassanzadeh (1)

Mahboubeh Rostami (1)

Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization

Style	Citing Format
MLA	Butini S, et al.. "Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization." Journal of Medicinal Chemistry, vol. 67, no. 3, 2024, pp. 1758-1782.
APA	Butini S, Grether U, Jung KM, Ligresti A, Allara M, Postmus AGJ, Maramai S, Brogi S, Papa A, Carullo G, Sykes D, Veprintsev D, Federico S, Grillo A, Di Guglielmo B, Ramunno A, Stevens AF, Heer D, Lamponi S, ... Campiani G (2024). Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization. Journal of Medicinal Chemistry, 67(3), 1758-1782.
Chicago	Butini S, Grether U, Jung KM, Ligresti A, Allara M, Postmus AGJ, Maramai S, et al.. "Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization." Journal of Medicinal Chemistry 67, no. 3 (2024): 1758-1782.
Harvard	Butini S et al. (2024) 'Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization', Journal of Medicinal Chemistry, 67(3), pp. 1758-1782.
Vancouver	Butini S, Grether U, Jung KM, Ligresti A, Allara M, Postmus AGJ, et al.. Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization. Journal of Medicinal Chemistry. 2024;67(3):1758-1782.
BibTex	@article{ author = {Butini S and Grether U and Jung KM and Ligresti A and Allara M and Postmus AGJ and Maramai S and Brogi S and Papa A and Carullo G and Sykes D and Veprintsev D and Federico S and Grillo A and Di Guglielmo B and Ramunno A and Stevens AF and Heer D and Lamponi S and Gemma S and Benz J and Di Marzo V and Van Der Stelt M and Piomelli D and Campiani G}, title = {Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization}, journal = {Journal of Medicinal Chemistry}, volume = {67}, number = {3}, pages = {1758-1782}, year = {2024} }
RIS	TY - JOUR AU - Butini S AU - Grether U AU - Jung KM AU - Ligresti A AU - Allara M AU - Postmus AGJ AU - Maramai S AU - Brogi S AU - Papa A AU - Carullo G AU - Sykes D AU - Veprintsev D AU - Federico S AU - Grillo A AU - Di Guglielmo B AU - Ramunno A AU - Stevens AF AU - Heer D AU - Lamponi S AU - Gemma S AU - Benz J AU - Di Marzo V AU - Van Der Stelt M AU - Piomelli D AU - Campiani G TI - Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization JO - Journal of Medicinal Chemistry VL - 67 IS - 3 SP - 1758 EP - 1782 PY - 2024 ER -

Style

Citing Format

MLA

Butini S, et al.. "Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization." Journal of Medicinal Chemistry, vol. 67, no. 3, 2024, pp. 1758-1782.

APA

Butini S, Grether U, Jung KM, Ligresti A, Allara M, Postmus AGJ, Maramai S, Brogi S, Papa A, Carullo G, Sykes D, Veprintsev D, Federico S, Grillo A, Di Guglielmo B, Ramunno A, Stevens AF, Heer D, Lamponi S, ... Campiani G (2024). Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization. Journal of Medicinal Chemistry, 67(3), 1758-1782.

Chicago

Butini S, Grether U, Jung KM, Ligresti A, Allara M, Postmus AGJ, Maramai S, et al.. "Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization." Journal of Medicinal Chemistry 67, no. 3 (2024): 1758-1782.

Harvard

Butini S et al. (2024) 'Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization', Journal of Medicinal Chemistry, 67(3), pp. 1758-1782.

Vancouver

Butini S, Grether U, Jung KM, Ligresti A, Allara M, Postmus AGJ, et al.. Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization. Journal of Medicinal Chemistry. 2024;67(3):1758-1782.

BibTex

@article{ author = {Butini S and Grether U and Jung KM and Ligresti A and Allara M and Postmus AGJ and Maramai S and Brogi S and Papa A and Carullo G and Sykes D and Veprintsev D and Federico S and Grillo A and Di Guglielmo B and Ramunno A and Stevens AF and Heer D and Lamponi S and Gemma S and Benz J and Di Marzo V and Van Der Stelt M and Piomelli D and Campiani G}, title = {Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization}, journal = {Journal of Medicinal Chemistry}, volume = {67}, number = {3}, pages = {1758-1782}, year = {2024} }

RIS

TY - JOUR
AU - Butini S
AU - Grether U
AU - Jung KM
AU - Ligresti A
AU - Allara M
AU - Postmus AGJ
AU - Maramai S
AU - Brogi S
AU - Papa A
AU - Carullo G
AU - Sykes D
AU - Veprintsev D
AU - Federico S
AU - Grillo A
AU - Di Guglielmo B
AU - Ramunno A
AU - Stevens AF
AU - Heer D
AU - Lamponi S
AU - Gemma S
AU - Benz J
AU - Di Marzo V
AU - Van Der Stelt M
AU - Piomelli D
AU - Campiani G
TI - Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. Sars, Structural Analysis, and Biological Characterization
JO - Journal of Medicinal Chemistry
VL - 67
IS - 3
SP - 1758
EP - 1782
PY - 2024
ER -

Science Communicator Platform

Authors

Abstract